Policy changes Backwork has recorded, newest first. The most recent change on record is from October 2, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
82,180 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Orthoptic Training for the Treatment of Vision or Learning Disabilities | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Ophthalmologic Techniques for the Evaluation of Glaucoma | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Patisiran Lipid Complex (Onpattro) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Pegaspargase (Oncaspar) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Onasemnogene Abeparvovec-xioi (Zolgensma) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | OnabotulinumtoxinA (Botox) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Omalizumab Products: Omalizumab (Xolair); Omalizumab-igec (Omlyclo) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Olipudase Alfa-rpcp (Xenpozyme) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Octreotide Suspension (Sandostatin LAR Depot), Octreotide Acetate for Injectable Suspension | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Pegfilgrastim (Neulasta); Pegfilgrastim-jmdb (Fulphila); Pegfilgrastim--pbbk (Fylnetra); Pegfilgrastim- apgf (Nyvepria); Pegfilgrastim-fpgk (Stimufed); Pegfilgrastim-cbqv (Udenyca); Pegfilgrastim-bmez (Ziextenzo) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Nutritional Treatment of Inborn Errors of Metabolism | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Nusinersen (Spinraza) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Romiplostim(Nplate) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Noninvasive Imaging Techniques for Evaluation and Monitoring of Chronic Liver Diseases | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Non-invasive Positive Pressure Ventilators (In-Home Use) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Non-Contact Ultrasound Treatment for Wounds | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Nonfamilial Genetic Testing for Breast Cancer Risk Assessment | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Nivolumab/Relatlimab-rmbw (Opdualag) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Nivolumab and Hyaluronidase-nvhy (Opdivo Qvantig) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Nivolumab (Opdivo) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Next-Generation Sequencing for the Assessment of Measurable Residual Disease | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Nerve Graft with Radical Prostatectomy | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Remote Electrical Neuromodulation (REN) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Negative Pressure Wound Therapy in the Outpatient Setting | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Nedosiran (Rivfloza) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Necitumumab (Portrazza) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Natalizumab (Tysabri), Natalizumab-sztn (Tyruko) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Myocardial Sympathetic Innervation Imaging for Individuals with Heart Failure | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | RimabotulinumtoxinB (Myobloc) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Multiple Sclerosis Products:(Ocrelizumab [Ocrevus], Ocrelizumab and Hyaluronidase-ocsq [Ocrevus Zunovo], Ublituximab-xiiy [Briumvi]) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Multi-biomarker Testing for Rheumatoid Arthritis | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | MRI-guided Laser-induced Thermotherapy for Neurological Indications | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Tafasitamab-cxix (Monjuvi) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Molecular Markers in Fine Needle Aspirates of the Thyroid | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Mogamulizumab-kpkc (Poteligeo) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Mitomycin (Zusduri) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Mirikizumab-mrkz (Omvoh) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Microwave Ablation for Oncologic Tumors | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Microprocessor-Controlled Prostheses for the Lower Limb | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Methoxy Polyethylene Glycol-Epoetin Beta (Mircera) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Vestronidase Alfa-vjbk(Mepsevii) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Mepolizumab (Nucala) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Mechanized Axial Spinal Distraction Therapy Devices | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Mastectomy for Gynecomastia | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | FDA-Approved Indications | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Manipulation Under Anesthesia (MUA) of the Musculoskeletal System | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Mammography | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Reduction Mammaplasty (Non-Cancerous) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Lymphatic Physiologic Microsurgery for Breast Cancer-Related Lymphedema | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Voretigene Neparvovec-rzyl (Luxturna) | Metadata changed |